Name: Richard Bucala Richard Bucala MIF World Scientific Publishing Company
Author: Christine N Metz and Richard Bucala

أعلان

نحن نحترم حقوق الملكية الفكرية اذا رأيت كتاب له حقوق ملكية فضلاً أبلغنا فوراً لحذفه

بحث عن كتاب

أعلان

تحميل كتاب Richard Bucala Richard Bucala MIF World Scientific Publishing Company PDF

المؤلف : Christine N Metz and Richard Bucala

التصنيف : كتب منوعة

الفئة : Biology Books

سنة النشر : 2007

عدد الصفحات : غير محدد

عن الكتاب : 2007م - 1443هـ نبذه عن الكتاب: Although first described as a soluble activity produced by activated T cells nearly four decades ago, interest in macrophage migration inhibitory factor (MIF) was rekindled when the mouse homolog of this protein was identified to be secreted from the anterior pituitary gland in a hormone-like fashion (Bernhagen et al., 1993). Initially, MIF was shown to play a critical role in the host inflammatory response to endotoxin. Further studies showed that the inflammatory activity of MIF was mediated by its ability to promote proinflammatory cytokine release (Calandra et al., 1994) and to suppress the anti-inflammatory effects of glucocorticoids (Calandra et al., 1995; Bacher et al., 1996). Since the identification of MIF as a unique proinflammatory molecule and the development of neutralizing monoclonal antibodies, several reports have been published describing the role of MIF in inflammatory diseases, including arthritis, glomerulonephritis, peritonitis, and the delayed-type hypersensitivity reaction. Clinical evidence demonstrating increased MIF expression during inflammatory disease pathogenesis further supports the potential role of MIF in inflammation. In addition to its role in the inflammatory response, MIF has been shown to exhibit growth-promoting activities. Recent investigations by two independent laboratories have revealed that immunoneutralization of MIF can inhibit tumor growth and angiogenesis (Chesney et al., 1999; Shimizu et al., 1999b). Further-more, MIF has been shown to inactivate p53, a potent tumor suppressor molecule (Hudson et al., 1999) supporting the role of MIF in cellular proliferation. Several chronic inflammatory conditions are associated with the development of tumors. Therefore, the identification of MIF as a suppressor of p53 activity might provide a mechanistic link between inflammation and tumorigenesis. .

أعلان

كتب pdf

أعلان

الملكية الفكرية محفوظة لمؤلف الكتاب المذكور فى حالة وجود مشكلة بالكتاب الرجاء الإبلاغ من خلال الايميل الخاص بنا فى صفحة حقوق النشر أو من خلال صفحتنا على الفيس بوك.

نبذة عن كتاب Richard Bucala Richard Bucala MIF World Scientific Publishing Company

كتاب Richard Bucala Richard Bucala MIF World Scientific Publishing Company

2007م - 1443هـ نبذه عن الكتاب: Although first described as a soluble activity produced by activated T cells nearly four decades ago, interest in macrophage migration inhibitory factor (MIF) was rekindled when the mouse homolog of this protein was identified to be secreted from the anterior pituitary gland in a hormone-like fashion (Bernhagen et al., 1993). Initially, MIF was shown to play a critical role in the host inflammatory response to endotoxin. Further studies showed that the inflammatory activity of MIF was mediated by its ability to promote proinflammatory cytokine release (Calandra et al., 1994) and to suppress the anti-inflammatory effects of glucocorticoids (Calandra et al., 1995; Bacher et al., 1996). Since the identification of MIF as a unique proinflammatory molecule and the development of neutralizing monoclonal antibodies, several reports have been published describing the role of MIF in inflammatory diseases, including arthritis, glomerulonephritis, peritonitis, and the delayed-type hypersensitivity reaction. Clinical evidence demonstrating increased MIF expression during inflammatory disease pathogenesis further supports the potential role of MIF in inflammation. In addition to its role in the inflammatory response, MIF has been shown to exhibit growth-promoting activities. Recent investigations by two independent laboratories have revealed that immunoneutralization of MIF can inhibit tumor growth and angiogenesis (Chesney et al., 1999; Shimizu et al., 1999b). Further-more, MIF has been shown to inactivate p53, a potent tumor suppressor molecule (Hudson et al., 1999) supporting the role of MIF in cellular proliferation. Several chronic inflammatory conditions are associated with the development of tumors. Therefore, the identification of MIF as a suppressor of p53 activity might provide a mechanistic link between inflammation and tumorigenesis. .

هذا الكتاب من تأليف Christine N Metz and Richard Bucala و حقوق الكتاب محفوظة لصاحبها

أعلان